USFDA nod for Natco Pharma’s anti-cancer generic drug
USFDA nod for Natco Pharma’s anti-cancer generic drug.....»»
USFDA nod for Natco Pharma’s anti-cancer generic drug
USFDA nod for Natco Pharma’s anti-cancer generic drug.....»»
Natco gets USFDA nod for 2 products
Natco gets USFDA nod for 2 products.....»»
Natco gets USFDA nod for 2 products
Natco gets USFDA nod for 2 products.....»»
Alembic Pharma gets final approval from USFDA for OCD treatment drug
Alembic Pharma gets final approval from USFDA for OCD treatment drug.....»»
Zydus Cadila gets tentative nod from USFDA to market cancer drug
Zydus Cadila gets tentative nod from USFDA to market cancer drug.....»»
Zydus Cadila gets tentative nod from USFDA to market cancer drug
Zydus Cadila gets tentative nod from USFDA to market cancer drug.....»»
Zydus Cadila gets tentative nod from USFDA to market cancer drug
Zydus Cadila gets tentative nod from USFDA to market cancer drug.....»»
40 pharma companies interested in producing anti COVID-19 drug, DRDO tells Madras High Court
40 pharma companies interested in producing anti COVID-19 drug, DRDO tells Madras High Court.....»»
BDR Pharma ties up Eli Lilly for COVID-19 drug
BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»
BDR Pharma ties up Eli Lilly for COVID-19 drug
BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»
Natco Pharma signs pact with Eli Lilly for Baricitinib
Natco Pharma signs pact with Eli Lilly for Baricitinib.....»»
Natco Pharma rallies 7% as firm seeks nod for Covid medicine Molnupiravir
Natco Pharma rallies 7% as firm seeks nod for Covid medicine Molnupiravir.....»»
20-30% new products may be under USFDA lens
20-30% new products may be under USFDA lens.....»»
Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelled
Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelled.....»»
Bull run in drug stocks face first hurdle as old headache returns
Bull run in drug stocks face first hurdle as old headache returns.....»»
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»
Dr. Reddy’s to sell U.S, Canada territory rights of anti-migraine drug
Dr. Reddy’s to sell U.S, Canada territory rights of anti-migraine drug.....»»
Dr. Reddy’s to sell U.S, Canada territory rights of anti-migraine drug
Dr. Reddy’s to sell U.S, Canada territory rights of anti-migraine drug.....»»
Pharma a long-term growth story; consolidation likely in IT: Andrew Holland
Pharma a long-term growth story; consolidation likely in IT: Andrew Holland.....»»